LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effects of a drug called Voraxaze when it's
routinely given in combination with methotrexate and rituximab, the standard treatment for
CNSL.